Project Name: Novartis Re-imagining Care Pathways Collaborative Working Project (“NRCP CWP”) for West Midland Cancer Alliance Nuclear Medicine Service Mapping

Project Summary: 

The Reimagining Care Pathways CWP is a service offered by Novartis, which comprises a series of workshops aimed at providing pathway mapping support to the CW Partner’s healthcare and service teams in order to: 

  1. Improve efficiency and service effectiveness for the benefit of patient care.
  2. Address the local challenges they face in the delivery of patient care.

  3. Map regional referral networks across the footprint of the West Midland Cancer Alliance.

The program facilitates area teams (Trust or ICS) to identify areas for efficiency within their service for prioritisation. 

This CWP will be carried out in collaboration with The West Midlands Cancer Alliance (WMCA), and the following 5 trusts; University Hospitals Birmingham NHS Foundation Trust (UHB), University Hospitals Coventry and Warwickshire NHS Trust (UHCW), University Hospitals of North Midlands NHS Trust (UHNM) and South Warwickshire University NHS Foundation Trust (SWFT), Shrewsbury and Telford Hospital NHS Trust (SATH).

WMCA will provide system-level oversight and coordination of stakeholder engagement aligned to regional priorities.

Expected Benefits: 

Anticipated Benefits for Patients:

  • Improvement of clinical pathways which may result in potentially fewer visits and shorter waiting times due to a more efficient clinical pathway.  
  • May support faster and more equitable access to the complete range of NICE approved treatment options.    
  • Quality care improvements aligned to established best practices.  

Anticipated Benefits for the Organisation(s):

  • Improved understanding of the current service pathway, and associated efficiencies and inefficiencies.
  • Potential to lead to solutions which could allow the CW Partner’s organisation to enhance both patient experience and outcomes.

Anticipated Benefits for Novartis:

  • Better understanding of patients’, carers and customers’ needs, which may inform future non-promotional service design approaches, in compliance with the ABPI Code.

Start Date & Expected Duration: July 2026, 14 weeks 

FA-11751727 | August 2026